A Fortune 500 company and leading medical device manufacturer received a 483 warning letter, inclusive of 14 observations, as a result of an FDA inspection. Discover how Advanced Clinical provided program managerial oversight and execution-level consultants to complete the required activities.
.png "Screenshot (989)")